Exact Sciences Corp (EXAS)
130.52
+3.38 +2.66%
NASDAQ
Apr 15, 20:00
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 1.491B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -5.54 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -848.53M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 78.62% |
| Profit Margin (Quarterly) | -93.67% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 22.07B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 13.23 |
| PE Ratio | -- |
| Price to Book Value | 7.817 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.5666 |
| Free Cash Flow (Quarterly) | 94.83M |
| Return on Equity | Upgrade |
View All EXAS News
News
-
WireHeadlineTime (ET)
-
PR Newswire04/14 06:00
-
Yahoo04/12 07:26
-
PR Newswire04/08 06:00
-
Yahoo04/06 15:56
-
Yahoo04/06 11:11
-
SA Breaking News03/31 10:51
-
Yahoo03/29 12:07
-
Yahoo03/26 12:17
-
SA Breaking News03/25 11:41
-
Yahoo03/23 12:56
-
Yahoo03/18 12:14
-
Yahoo03/18 11:30
-
Yahoo03/16 08:00
-
Yahoo03/09 09:00
-
Yahoo03/08 06:49
-
Yahoo03/05 09:00
-
Yahoo03/04 08:30
-
PR Newswire02/22 06:00
-
Yahoo02/21 06:17
-
MT Newswires02/18 11:24
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 05/06/2020 17:00 EDT | Earnings Calls | Q1 2020 Earnings Call |
| 05/06/2020 00:00 | Earnings Results | Q1 2020 Earnings Results |
| 07/23/2020 11:00 EDT | Agm | 2019 Annual General Meeting |
| 07/30/2020 17:00 EDT | Earnings Calls | Q2 2020 Earnings Call |
| 07/30/2020 00:00 | Earnings Results | Q2 2020 Earnings Results |
| 10/29/2020 17:00 EDT | Earnings Calls | Q3 2020 Earnings Call |
| 10/29/2020 00:00 | Earnings Results | Q3 2020 Earnings Results |
| 02/16/2021 00:00 | Earnings Results | Q4 2020 Earnings Results |
| 02/16/2021 17:00 EST | Earnings Calls | Q4 2020 Earnings Call |
| 05/04/2021 00:00 | Earnings Results | Q1 2021 Earnings Results |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- Description: Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact’s Cologuard screening test, a non-invasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a genetic-based treatment selection test for breast, prostate, and colon cancers. With the acquisitions of Base Genomics and Thrive Earlier Detection, Exact is building a multi-cancer early screening test to detect over 14 cancers, a test that would be one of earliest entrants in liquid biopsy (blood-based) cancer screening.
- URL: https://www.exactsciences.com
- Investor Relations URL: https://investor.exactsciences.com/investor-relations/default.aspx
- HQ State/Province: Wisconsin
- Sector: Healthcare
- Industry: Diagnostics & Research
- Equity Style: Mid Cap/Growth
- Next Earnings Release: May. 04, 2021
- Last Earnings Release: Feb. 16, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 130.52 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| ARKG | ARK Genomic Revolution ETF | 4.91% |
| DFRIX | Delaware Smid Cap Growth R | 4.33% |
| BBH | VanEck Vectors Biotech ETF | 4.29% |
| FBT | First Trust NYSE Arca Biotech ETF | 3.23% |
| ETCGX | Eventide Gilead C | 3.10% |
| GOFFX | Invesco Global Opportunities R5 | 2.84% |
| EARK.NO | Emerge ARK Global Disruptive Innovt ETF | 2.78% |
| ARKK | ARK Innovation ETF | 2.78% |
| APDMX | Artisan Mid Cap Advisor | 2.41% |
| ZUH.TO | BMO Eq Wght US HlthCare Hdgd to CAD ETF | 2.22% |
| TRUZX | T. Rowe Price New Horizons Z | 2.07% |
| JMGQX | JPMorgan Mid Cap Growth R4 | 1.15% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- EXAS Tweets Stocktwits
Advertisement
